While CT remains the gold standard in Radiation Therapy treatment planning, advances in MRI are arming facilities with remarkable new advantages:
- Superior soft tissue contrast
- Potential for more accurate delineation of target volume and surrounding OARs
- Tumor activity information on cellular density, tumor biology
The white paper “MR-only RT Planning for the Brain and Pelvis with Synthetic CT” delivers evidence that MRI can advance clinical capabilities and treatment planning outcomes.
